Global Aseptic Sampling Market to Reach $1.6 Billion by 2027
Amid the COVID-19 crisis, the global market for Aseptic Sampling estimated at US$731.8 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at aCAGR of 12.3% over the period 2020-2027. Manual Aseptic Sampling, one of the segments analyzed in the report, is projected to record 13.3% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Automatic Aseptic Sampling segment is readjusted to a revised 10.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $197.3 Million, While China is Forecast to Grow at 16.1% CAGR
The Aseptic Sampling market in the U.S. is estimated at US$197.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$365.3 Million by the year 2027 trailing a CAGR of 16.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.5% and 10.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.We bring years of research experience to this 9th edition of our report. The 371-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Competitors identified in this market include, among others,
- Compagnie de Saint-Gobain
- Danaher Corporation
- Flownamics Analytical Instruments, Inc.
- GEA Group AG
- GEMu Gebr. Muller Apparatebau GmbH & Co. KG
- Keofitt A/S
- Lonza Group AG
- Merck KgaA
- Qualitru Sampling Systems.
- Sartorius Stedim Biotech SA
- Thermo Fisher Scientific, Inc.
- Trace Analytics, LLC.
- W. L. Gore & Associates, Inc.